The US FDA may now have a legislative mandate to wade into regulation of medical practice with its development of opioid prescribing guidelines, but Commissioner Scott Gottlieb only seems interested in the agency getting a toe wet.
Gottlieb told the National Academies of Sciences, Engineering and Medicines (NASEM) committee researching evidence-based opioid prescribing guidelines that he does...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?